跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Neovis - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Neovis
Approved
STANDARD
Neovis
Tablets (India) Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
49786b86f820929c
Company
Tablets (India) Limited
Type
Standard
Approval Details
Approval Id
49786b86f820929c
Drug Approval Philippines Name
Neovis
Product Name
Neovis
Registration Number
DRP-6823-04
Brand Name
Neovis
Generic Name
Neostigmine (as methylsulfate)
Dosage Form
Solution for Injection (IM/IV/SC)
Dosage Strength
500 mcg/mL
Manufacturer
Tablets (India) Limited
Importer
Medinova Pharmaceutical Inc
Distributor
Vispomed Corporation
Company Detail Path
/organization/tablets-india-limited
Issuance Date
12 October 2022
Expiry Date
01 September 2028
Pharmacologic Category
Cholinesterase Inhibitors
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
49786b86f820929c
Type
Standard
Back to Philippines FDA Approvals